Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Arndt

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Open Forum Infectious Diseases|October 10, 2022
Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron EpochRaymund R Razonable, Sidna M Tulledge-Scheitel, Sara N Hanson, et al.
Annals of the Rheumatic Diseases|December 4, 2014
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)A J Mohammad, A Hot, F Arndt, et al.
Neurology|October 22, 1998
Creutzfeldt-Jakob disease: neurophysiologic visual impairmentsJ de Seze, J C Hache, P Vermersch, et al.
Nature Cell Biology|June 13, 2022
Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cellsDaniel Rosebrock, Sneha Arora, Naresh Mutukula, et al.
Frontiers in Oncology|September 1, 2023
Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLCMichael Cekay, Philipp F Arndt, Rio Dumitrascu, et al.
Mayo Clinic Proceedings|May 5, 2022
Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019John O'Horo, Douglas W Challener, Ryan J Anderson, et al.
The Journal of Infectious Diseases|September 20, 2022
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochRaymund R Razonable, John C O'Horo, Sara N Hanson, et al.
Mayo Clinic Proceedings|February 5, 2022
Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta VariantJohn C O'Horo, Douglas W Challener, Leigh Speicher, et al.
BMC Genomics|June 30, 2014
Distribution of segmental duplications in the context of higher order chromatin organisation of human chromosome 7Grit Ebert, Anne Steininger, Robert Weißmann, et al.
EMBO Molecular Medicine|February 17, 2019
Targeting miR-34a/<i>Pdgfra</i> interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasiaJordi Ruiz-Camp, Jennifer Quantius, Ettore Lignelli, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Open Forum Infectious Diseases|October 10, 2022
Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron EpochRaymund R Razonable, Sidna M Tulledge-Scheitel, Sara N Hanson, et al.
Annals of the Rheumatic Diseases|December 4, 2014
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)A J Mohammad, A Hot, F Arndt, et al.
Neurology|October 22, 1998
Creutzfeldt-Jakob disease: neurophysiologic visual impairmentsJ de Seze, J C Hache, P Vermersch, et al.
Nature Cell Biology|June 13, 2022
Enhanced cortical neural stem cell identity through short SMAD and WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cellsDaniel Rosebrock, Sneha Arora, Naresh Mutukula, et al.
Frontiers in Oncology|September 1, 2023
Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLCMichael Cekay, Philipp F Arndt, Rio Dumitrascu, et al.
Mayo Clinic Proceedings|May 5, 2022
Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019John O'Horo, Douglas W Challener, Ryan J Anderson, et al.
The Journal of Infectious Diseases|September 20, 2022
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochRaymund R Razonable, John C O'Horo, Sara N Hanson, et al.
Mayo Clinic Proceedings|February 5, 2022
Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta VariantJohn C O'Horo, Douglas W Challener, Leigh Speicher, et al.
BMC Genomics|June 30, 2014
Distribution of segmental duplications in the context of higher order chromatin organisation of human chromosome 7Grit Ebert, Anne Steininger, Robert Weißmann, et al.
EMBO Molecular Medicine|February 17, 2019
Targeting miR-34a/<i>Pdgfra</i> interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasiaJordi Ruiz-Camp, Jennifer Quantius, Ettore Lignelli, et al.
Pageof 12